Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?

R Leonard; R Ballinger; D Cameron; P Ellis; L Fallowfield; M Gosney; L Johnson; L S Kilburn; A Makris; J Mansi; M Reed; A Ring; A Robinson; P Simmonds; G. Thomas; J M Bliss

doi:10.1038/bjc.2011.377

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?

R Leonard, R Ballinger, D Cameron, P Ellis, L Fallowfield, M Gosney, L Johnson, L S Kilburn, A Makris, J Mansi, M Reed, A Ring, A Robinson, P Simmonds, G. Thomas, J M Bliss

Research output: Contribution to journal › Article › peer-review

Abstract / Description of output

The ACTION trial was initiated to provide evidence from a randomised trial on the effects of chemotherapy in women aged over 70 years where evidence for risk and benefit are lacking.

Original language	English
Pages (from-to)	1260-1266
Number of pages	7
Journal	British Journal of Cancer
Volume	105
Issue number	9
DOIs	https://doi.org/10.1038/bjc.2011.377
Publication status	Published - 2011

Access to Document

10.1038/bjc.2011.377

Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase
Copyright © 2011 Cancer Research UK. BJC open access article
Final published version, 357 KB

http://www.nature.com/bjc/journal/v105/n9/full/bjc2011377a.html

Cite this

Leonard, R., Ballinger, R., Cameron, D., Ellis, P., Fallowfield, L., Gosney, M., Johnson, L., Kilburn, L. S., Makris, A., Mansi, J., Reed, M., Ring, A., Robinson, A., Simmonds, P., Thomas, G., & Bliss, J. M. (2011). Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase? British Journal of Cancer, 105(9), 1260-1266. https://doi.org/10.1038/bjc.2011.377

@article{d6dfd4429da14d7c877caaea8c064e80,

title = "Adjuvant chemotherapy in older women (ACTION) study - what did we learn from the pilot phase?",

abstract = "The ACTION trial was initiated to provide evidence from a randomised trial on the effects of chemotherapy in women aged over 70 years where evidence for risk and benefit are lacking.",

author = "R Leonard and R Ballinger and D Cameron and P Ellis and L Fallowfield and M Gosney and L Johnson and Kilburn, {L S} and A Makris and J Mansi and M Reed and A Ring and A Robinson and P Simmonds and G. Thomas and Bliss, {J M}",

year = "2011",

doi = "10.1038/bjc.2011.377",

language = "English",

volume = "105",

pages = "1260--1266",

journal = "British Journal of Cancer",

issn = "1532-1827",

publisher = "Nature Publishing Group",